TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Ford Leads Autos Higher as Earnings Fuel Stock Gains
Play
INVESTING

Stock Market Today With Jim Cramer: How to Trade Ford

  • By Vidhi Choudhary
  • 18 minutes ago
Ford Leads Autos Higher as Earnings Fuel Stock Gains
INVESTING

Stock Market Today With Jim Cramer: How to Trade Ford

  • By Vidhi Choudhary
  • 18 minutes ago
Jim Cramer Live Dec. 9
JIM CRAMER

Jim Cramer on Jobs Report, Robinhood, Peloton, Ford, Chevron and Johnson & Johnson

  • By Katherine Ross
  • 6 hours ago
NYSE Lead
MARKETS

Stocks Rise as Weak Jobs Report Boosts Stimulus Bets

  • By Joseph Woelfel
  • 1 hour ago
Peloton Lead
INVESTING

Peloton, Johnson & Johnson, Snap - Friday's Premarket Movers

  • By Vidhi Choudhary
  • 7 hours ago
NYSE Stock Market Wall Street Trader
MARKETS

Dow Futures Extend Gains On Senate Stimulus Vote, Vaccine Rollout: January Jobs Report Disappoints

  • By Martin Baccardax
  • 7 hours ago
U.S. Stocks Rise After Strong Jobs Report
MARKETS

Peloton, Jobs Report, Ford: 5 Things You Must Know Friday

  • By Joseph Woelfel
  • 7 hours ago
vaccine-2
INVESTING

Johnson & Johnson Seeks Emergency Use OK for Covid Vaccine

  • By Anne Stanley
  • 21 hours ago
PRESS RELEASES

Johnson & Johnson Announces Submission Of Application To The U.S. FDA For Emergency Use Authorization Of Its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate

  • By PR Newswire
  • 22 hours ago
Opioid Epidemic War Is Being Fought at the Local Level
Video

McKinsey Agrees to $550 Million Opioid-Related Settlement

  • Feb 4, 2021 10:22 AM EST
Opioid Litigants Get Boost From Senate Report
INVESTING

McKinsey Reportedly Agrees to $550M Opioid-Claim Settlement

  • By M. Corey Goldman
  • Feb 4, 2021 6:37 AM EST
PRESS RELEASES

FogChain Announces Definitive Agreement For The Acquisition Of Avisa Pharma Inc.

  • By PR Newswire
  • Feb 2, 2021 11:26 AM EST
China's Telecom Giants Surge As NYSE Backtracks On ADR Delisting Plan, WuXi Biologics Slumps As Insider Sells Again
INVESTING

Dow Futures Climb As Reddit Retail Grip Fades; GameStop, AMC Plunge

  • By Martin Baccardax
  • Feb 2, 2021 8:34 AM EST
Moderna
STOCKS

Moderna Slides as Bank of America Cuts to Underperform on Valuation

  • By Rob Lenihan
  • Feb 1, 2021 2:51 PM EST
Novavax Lead
INVESTING

Novavax, Siebert Financial: 5 Top Stock Gainers for Friday

  • By Rob Lenihan
  • Jan 29, 2021 4:30 PM EST
NYSE Stock Market Wall Street Trader
MARKETS

Stocks Tumble as Wall Street Gripped by GameStop Trading Frenzy

  • By Joseph Woelfel
  • Jan 29, 2021 4:28 PM EST
J&J - More Exciting Than Merck
INVESTING

Sell Johnson & Johnson on Covid Vaccine News? Look at Support First

  • By Bret Kenwell
  • Jan 29, 2021 2:44 PM EST
Will Johnson & Johnson (JNJ) Stock Rise as Wells Fargo Sees Solid Growth?
INVESTING

Stock Market Today: Buy Johnson & Johnson When It Drops

  • By Vidhi Choudhary
  • Jan 29, 2021 2:35 PM EST
BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters
INVESTING

Pfizer CEO Says It Can Supply Promised Vaccine Doses

  • By Dan Weil
  • Jan 29, 2021 1:47 PM EST
How JNJ's Chief Medical Officer Fell In Love With Science -- In a Bakery
Video

Fundamentals of JNJ Speak For Themselves: Analyst

  • Jan 29, 2021 12:55 PM EST
Hong Kong Health Experts Say Delay To AstraZeneca Vaccine Effort Will Not Hinder Government Plans To Secure Covid-19 Shots
INVESTING

AztraZeneca Covid-19 Vaccine Gets EU Approval for Use in All Adults

  • By Rob Lenihan
  • Jan 29, 2021 11:45 AM EST
robinhood (6)
JIM CRAMER

Jim Cramer's Top Analyst on GameStop, Robinhood, J&J, Stock Market Friday

  • By Katherine Ross
  • Jan 29, 2021 12:56 PM EST
Cramer: JNJ Deal Will Lead to a Buyback and Much More Upside
INVESTING

Johnson & Johnson, Eli Lilly, Caterpillar, Chevron - Friday's Premarket Movers

  • By Vidhi Choudhary
  • Jan 29, 2021 8:56 AM EST
No More Tears for Johnson & Johnson?
INVESTING

Johnson & Johnson COVID Vaccine Reaches 66% Efficacy Rate in Global Trials

  • By Martin Baccardax
  • Jan 29, 2021 9:35 AM EST
PRESS RELEASES

Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints In Interim Analysis Of Its Phase 3 ENSEMBLE Trial

  • By PR Newswire
  • Jan 29, 2021 8:00 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.